METROPOLITAN LIFE INSURANCE CO/NY - RELMADA THERAPEUTICS INC ownership

RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 98 filers reported holding RELMADA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.42 and the average weighting 0.3%.

Quarter-by-quarter ownership
METROPOLITAN LIFE INSURANCE CO/NY ownership history of RELMADA THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$61,120
+94.9%
1,6510.0%0.00%
+200.0%
Q2 2022$31,352
-29.6%
1,6510.0%0.00%
-50.0%
Q1 2022$44,560
-57.6%
1,651
-64.6%
0.00%
+100.0%
Q4 2021$105,080
-14.0%
4,6640.0%0.00%
-50.0%
Q3 2021$122,243
-18.1%
4,6640.0%0.00%0.0%
Q2 2021$149,295
-9.1%
4,6640.0%0.00%0.0%
Q1 2021$164,219
+9.8%
4,6640.0%0.00%0.0%
Q4 2020$149,574
-14.8%
4,6640.0%0.00%
-33.3%
Q3 2020$175,460
-15.9%
4,6640.0%0.00%
-25.0%
Q2 2020$208,7144,6640.00%
Other shareholders
RELMADA THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
VR Adviser, LLC 668,440$25,147,0004.92%
TANG CAPITAL MANAGEMENT LLC 500,000$18,810,0003.40%
ACUTA CAPITAL PARTNERS, LLC 277,000$10,421,0002.83%
PARSONS CAPITAL MANAGEMENT INC/RI 455,137$17,122,0001.67%
RTW INVESTMENTS, LP 1,511,337$56,857,0001.37%
Avoro Capital Advisors LLC 1,500,000$56,430,0000.80%
Pegasus Asset Management, Inc. 26,958$1,014,0000.64%
RA Capital Management 781,290$29,392,0000.54%
TIEDEMANN ADVISORS, LLC 269,839$10,151,0000.49%
Boxer Capital, LLC 300,000$11,286,0000.39%
View complete list of RELMADA THERAPEUTICS INC shareholders